[ET Net News Agency, 13 August 2026] HANSOH PHARMA (03692) rose 3.3% to HK$34.6.
It hits an intra-day high of HK$34.62, and an intra-day low of HK$33.2. The total shares traded was 4.19 million, with a value of HK$142.28m. The active buy/sell ratio is 70:30, with net buying turnover of HK$54.6m. CHINA INNOVATION MARKET SER accounts for greatest net responsive buying turnover of HK$10.69m, with volume weighted average price of HK$34.003. ABN AMRO CLEARING HK accounts for greatest net responsive selling turnover of HK$15.57m, with volume weighted average price of HK$34.004.
The Hang Seng Index now rose 18 points, or less than 0.1% to 25,458; the Hang Seng China Enterprises Index now fell 1 point, or less than 0.1% to 8,445.
Basic Information| Nominal | 34.600 | % Chg | +3.28% |
| High | 34.620 | Low | 33.200 |
| Shares Tr | 4.19m | Turnover | 142.28m |
| 10-D SMA | 32.858 | %H.V | 40.113 |
| 20-D SMA | 32.708 | VWAP | 33.935 |
| 50-D SMA | 31.367 | RSI14 | 60.881 |
Status: Active buy/sell ratio is 70:30, with net buying turnover of HK$54.6m
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| HANSOH PHARMA (03692) | 34.60 | +3.28 |
| SIHUAN PHARM (00460) | 0.90 | +2.86 |
| GRAND PHARMA (00512) | 5.46 | +2.34 |
| SBP GROUP (01177) | 5.00 | +1.52 |
| HENGRUI PHARMA (01276) | 57.05 | +1.78 |
| LIVZON PHARMA (01513) | 26.48 | +0.61 |
| LUYE PHARMA (02186) | 2.18 | +3.56 |
| FOSUN PHARMA (02196) | 17.47 | +2.76 |
| SH PHARMA (02607) | 11.85 | +0.68 |
| CHINARES PHARMA (03320) | 4.95 | +1.12 |
(ed)
